Press "Enter" to skip to content

New patent for Novartis drug KISQALI

0
Copyright © DrugPatentWatch. Originally published at New patent for Novartis drug KISQALI

Annual Drug Patent Expirations for KISQALI
Annual Drug Patent Expirations for KISQALI

Kisqali is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug.

This drug has one hundred and sixty-four patent family members in fifty-one countries.

The generic ingredient in KISQALI is letrozole; ribociclib succinate. One supplier is listed for this compound. Additional details are available on the letrozole; ribociclib succinate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Novartis drug KISQALI
    DrugPatentWatch - Make Better Decisions